Endothelial factors after selective retrograde coronary venous bypass under different pressures.

Background: Selective retrograde coronary venous bypass (SRCVB) may be a promising treatment for patients with advanced coronary artery disease (CAD). The aim of this study is to investigate the effect of SRCVB on plasma endothelial factor levels in dog myocardial ischemic model, and explore the pos...

Descripción completa

Detalles Bibliográficos
Publicado en:Scandinavian Cardiovascular Journal Vol. 45; no. 6; pp. 369 - 374
Autores principales: Zhao Y, Gu TX, Zhang GW, Shi EY, Yu L, Wang C, Zhao, Ye, Gu, Tian-Xiang, Zhang, Guang-Wei, Shi, En-Yi, Yu, Lei, Wang, Chun
Formato: research Journal Article
Publicado: Taylor & Francis Ltd Dec2011
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104597307&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 104597307
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        14017431
        2UX
      jtl: Scandinavian Cardiovascular Journal
      issn: 14017431
      maglogo: Y
    pubinfo:
      dt: Dec2011
      vid: 45
      iid: 6
      pid: 377
      pub: Taylor & Francis Ltd
      place: Philadelphia, Pennsylvania
    artinfo:
      ui:
        104597307
        NLM22070402
        2011361537
        10.3109/14017431.2011.616219
        NLM22070402
        104597307
      ppf: 369
      ppct: 5
      formats:
      tig:
        atl: Endothelial factors after selective retrograde coronary venous bypass under different pressures.
      aug:
        au:
          Zhao Y
          Gu TX
          Zhang GW
          Shi EY
          Yu L
          Wang C
          Zhao, Ye
          Gu, Tian-Xiang
          Zhang, Guang-Wei
          Shi, En-Yi
          Yu, Lei
          Wang, Chun
        affil: Department of Cardiac Surgery, The First Affiliated Hospital of China Medical University, Shenyang, China
      sug:
        subj:
          Epithelial Cells Metabolism
          Endothelins Blood
          Myocardial Ischemia Surgery
          Myocardial Revascularization Methods
          Nitric Oxide Blood
          Perfusion Methods
          Animals
          Aorta, Thoracic Surgery
          Biological Markers Blood
          Coronary Angiography
          Models, Biological
          Dogs
          Female
          Male
          Myocardial Ischemia Blood
          Myocardial Ischemia Pathology
          Myocardial Ischemia Radiography
          Pressure
          Saphenous Vein Transplantation
          Time Factors
          Veins Surgery
          Female
          Male
      ab: Background: Selective retrograde coronary venous bypass (SRCVB) may be a promising treatment for patients with advanced coronary artery disease (CAD). The aim of this study is to investigate the effect of SRCVB on plasma endothelial factor levels in dog myocardial ischemic model, and explore the possible mechanisms. Methods: 24 crossbreed dogs were randomly divided into three groups: (1) control group; (2) SRCVB group with 60 mmHg perfusion pressure; (3) SRCVB group with 90 mmHg perfusion pressure. The posterior descending coronary artery (PDA) was ligated in all groups, and SRCVB was performed in the last two groups. The levels of plasma nitric oxide (NO) and endothelin (ET) at different time points were determined in each group. In SRCVB groups, ink and imaging agent were injected to the heart through SVG graft for assessment of vein perfusion. Results: At the acute period, there were significant increase in the plasma levels of NO and decrease in ET in SRCVB 90 mmHg group compared with the control (P < 0. 01), and a further improvement were found in SRCVB 60 mmHg group (P < 0. 01). The ink or imaging agent was found in the myocardial tissue and flowed back to right atrium through contralateral coronary vein. Conclusions: SRCVB with low level of perfusion pressure could provide effective perfusion for ischemic myocardium and alleviate the myocardial endothelial cell injury. It may be a new therapeutic strategy for severe CAD.
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N